Neurotrack, a company developing digital cognitive health tools, launched a three-minute digital assessment tool to screen for cognitive impairment during wellness appointments.
The digital exam is designed to help identify cognitive impairment and decline, an early indicator of neurodegenerative conditions like Alzheimer's. The tool can be used during a primary care annual wellness visit or...
Biogen has announced a new multiyear research study on cognitive decline that will be conducted using the Apple Watch and iPhone.
The observational study is being conducted in collaboration with Apple, according to the announcement, and is set to kick off later this year. The project's primary goal is to establish digital biomarkers for monitoring long-term cognitive performance and to spot early...
Switzerland-based MindMaze announced yesterday its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI) for an undisclosed sum.
According to the announcement, MindMaze will acquire a perpetual license to NMI’s rehabilitation technology and pick up NMI cofounder Dr. John Krakauer as its now chief medical and chief scientific advisor. Krakauer and...
A study focused on the impact that caring for an individual with Alzheimer's has on the caregiver's own brain and behavioral health has now moved into Phase II. This next phase of the Health-eBrain Study, done in collaboration with BrightFocus Foundation, Geoffrey Beene Foundation Alzheimer’s Intitiative, AnthroTronix and Mindoula, will be announced at the Global Alliance for Women’s Brain Health...
